Michigan Risk Score for PICC-Related Thrombosis
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Class I0–0
- Class II1–2
- Class III3–4
- Class IV5–10
The Michigan Risk Score for PICC-Related Thrombosis calculates predicting risk of deep vein thrombosis (DVT) in patients with peripherally inserted central catheter (PICC). Key inputs include another cvc present. Scores guide initiating targeted anticoagulation therapy, platelet monitoring, or hematology specialist referral. Routine clinical application promotes standardized evidence-based patient management.
Clinical Guidelines & Evidence
Predicts risk of deep vein thrombosis (DVT) in patients with peripherally inserted central catheter (PICC)
Clinical Indication
The Michigan Risk Score for PICC-Related Thrombosis is indicated for bedside clinical practice to support Predicts risk of deep vein thrombosis (DVT) in patients with peripherally inserted central catheter (PICC). It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with coagulopathy, thrombocytopenia, venous thromboembolism (DVT/PE), or hematologic neoplasms. Clinical application is indicated across Hematology-oncology services, bone marrow transplant units, anticoagulation clinics, and acute medical wards.
Limitations & Contraindications
Severe thrombocytopenia with concomitant microvascular thrombosis (TTP, HIT, DIC) represents a medical emergency requiring rapid intervention.
Clinical Pearls & Action Plan
Detailed history of heparin exposure, platelet count kinetics, and comprehensive coagulation profiles are vital in consumptive coagulopathies. Guideline pearl: Some validation studies have shown mixed results regarding accuracy.
Sum of points: Another CVC (+1), WBC >12 (+1), 2 lumens (+1), 3-4 lumens (+2), VTE >30 days prior (+2), VTE within 30 days (+3), Active cancer (+3)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| another_cvc_present | string | Yes | Is another central venous catheter (CVC) present when PICC is placed? |
| wbc_over_12 | string | Yes | Is white blood cell count > 12.0 × 10⁹/µL? |
| picc_lumens | string | Yes | Number of PICC lumens |
| history_of_vte | string | Yes | History of venous thromboembolism (VTE)? |
| active_cancer | string | Yes | Active cancer (on chemotherapy or cancer-related admission)? |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | Class I | 0.9% VTE probability |
| 1–2 | Class II | 1.6% VTE probability |
| 3–4 | Class III | 2.7% VTE probability |
| 5–10 | Class IV | 4.7% VTE probability |
Evidence-Based References (EBM)
- Chopra V, Kaatz S, Conlon A, Paje D, Grant PJ, Rogers MAM, et al. The Michigan Risk Score to predict peripherally inserted central catheter-associated thrombosis. J Thromb Haemost. 2017 Oct;15(10):1951-1962. doi: 10.1111/jth.13794.DOI: 10.1111/jth.13794
- Chopra V, Anand S, Hickner A, Buist M, Rogers MA, Saint S, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet. 2013 Jul 27;382(9889):311-25. doi: 10.1016/S0140-6736(13)60592-9.DOI: 10.1016/S0140-6736(13)60592-9
- Evans RS, Sharp JH, Linford LH, Lloyd JF, Tripp JS, Jones JP, et al. Risk of symptomatic DVT associated with peripherally inserted central catheters. Chest. 2010 Oct;138(4):803-10. doi: 10.1378/chest.10-0154.DOI: 10.1378/chest.10-0154